The STAT3 inhibitor compound (Stattic) was an SH2-domain inhibitor discovered by a high-throughput chemical library screen [109], and Stattic significantly attenuated EZH2 expression and local tumor invasion and outgrowth via targeting STAT3 [139]. The gene discussed is STAT3; the disease is neoplasm.